|Bid||200.60 x 800|
|Ask||200.82 x 1300|
|Day's Range||197.74 - 202.27|
|52 Week Range||186.83 - 369.69|
|Beta (5Y Monthly)||1.26|
|PE Ratio (TTM)||46.29|
|Earnings Date||Jul 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||321.41|
Subscribe to Yahoo Finance Plus to view Fair Value for ISRG
Intuitive’s Ion System and Siemens Healthineers Cios Spin FDA clearance offers seamless cone beam CT scans during robotic bronchoscopy proceduresSUNNYVALE, Calif., June 30, 2022 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the U.S. Food and Drug Administration has cleared the integration of a mobile cone-beam CT (CBCT) imaging technology and the Ion Endoluminal System used for robo
Companies are analyzing the costs and benefits of splitting their shares, with several big businesses recently announcing plans to do so.
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $202.59, moving +0.3% from the previous trading session.